Stay updated with breaking news from Marni Kottle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Total FY'23 Revenues of $2.42 Billion (+15% Y/Y and +20% Y/Y at Constant Currency); GAAP Diluted Earnings per Share of $0.87 (+16% Y/Y) and Non-GAAP Diluted...
SAN RAFAEL, Calif., Jan. 3, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 42nd...
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today...
BioMarin Pharmaceutical Inc. , a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives to enhance corporate governance and long-term shareholder...
SAN RAFAEL, Calif., Oct. 17, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a...